310 related articles for article (PubMed ID: 7832132)
1. Coronary microvascular response to intracoronary administration of nicorandil.
Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanism.
Nakae I; Matsumoto T; Horie H; Yokohama H; Omura T; Minai K; Matsui T; Nozawa M; Takahashi M; Sugimoto Y; Ito M; Izumi M; Nakamura Y; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 2000 Jun; 35(6):919-25. PubMed ID: 10836727
[TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine on human coronary arterial circulation.
Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
[TBL] [Abstract][Full Text] [Related]
4. Effective and safe dose of intracoronary nicorandil in man.
Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation.
Nishikawa Y; Kanki H; Ogawa S
J Cardiovasc Pharmacol; 1998 Jul; 32(1):21-8. PubMed ID: 9676716
[TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine triphosphate on human coronary circulation.
Shiode N; Kato M; Nakayama K; Shinohara K; Kurokawa J; Yamagata T; Matsuura H; Kajiyama G
Intern Med; 1998 Oct; 37(10):818-25. PubMed ID: 9840701
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
Wilson RF; White CW
Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
Duan T; Zhang J; Xiang D; Song R; Kong R; Xu D
Adv Clin Exp Med; 2019 Oct; 28(10):1409-1418. PubMed ID: 31638745
[TBL] [Abstract][Full Text] [Related]
9. Coronary vasodilatory action after a single dose of nicorandil.
Suryapranata H; Serruys PW; De Feyter PJ; Verdouw PD; Hugenholtz PG
Am J Cardiol; 1988 Feb; 61(4):292-7. PubMed ID: 2963519
[TBL] [Abstract][Full Text] [Related]
10. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
11. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
12. Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.
Inoue F; Hashimoto T; Fujimoto S; Uemura S; Kawamoto A; Dohi K
Heart Vessels; 1998; 13(5):229-36. PubMed ID: 10483772
[TBL] [Abstract][Full Text] [Related]
13. Safety and optimal dose of intracoronary adenosine 5'-triphosphate for the measurement of coronary flow reserve.
Sonoda S; Takeuchi M; Nakashima Y; Kuroiwa A
Am Heart J; 1998 Apr; 135(4):621-7. PubMed ID: 9539477
[TBL] [Abstract][Full Text] [Related]
14. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
[TBL] [Abstract][Full Text] [Related]
16. Effects of various doses of intracoronary verapamil on coronary resistance vessels in humans.
Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K; Ueda K
Jpn Circ J; 1997 Sep; 61(9):755-61. PubMed ID: 9293405
[TBL] [Abstract][Full Text] [Related]
17. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium.
Ghaleh B; Dubois-Randé JL; Hittinger L; Giudicelli JF; Berdeaux A
Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748
[TBL] [Abstract][Full Text] [Related]
18. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
Zijlstra F; Juillière Y; Serruys PW; Roelandt JR
Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211
[TBL] [Abstract][Full Text] [Related]
19. [Coronary flow after successful angioplasty in patients with acute myocardial infarction: comparison between coronary flow reserve by nicorandil and papaverine].
Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Hirozane T; Himura Y; Iga K; Gen H; Konishi T
J Cardiol; 2000 Mar; 35(3):175-80. PubMed ID: 10808424
[TBL] [Abstract][Full Text] [Related]
20. Angiographic response to a vasodilating drug, nicorandil, in patients with coronary artery disease.
Kishida H; Hata N; Kusama Y; Iwahara S; Sasaki Y; Mori N; Yasutake M; Koumi S; Takayama M; Munakata K
Jpn Heart J; 1990 Mar; 31(2):135-43. PubMed ID: 2141366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
